IDEAYA Biosciences, Inc. (IDYA) quarterly cash flow statement — complete operating, investing & financing history
IDEAYA Biosciences, Inc. (IDYA) cash flow statement — 9-year operating, investing & financing cash flows
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Cash from Operations | -93.48M | -88.21M | -75.17M | -90.5M | 142.21M | -62.47M | -60.34M | -121.66M | -49.23M | -32.88M | -43.81M | -23.75M | -30.17M | -33.46M | -27.84M | -23.37M | -24.17M | -19.99M | -19.65M | -16.66M |
| Operating CF Margin % | -912.72% | -995.95% | -1145.88% | -832.07% | 68.43% | - | - | -1737.93% | - | - | - | -605.35% | -375.39% | -944.13% | -353.32% | -581.05% | -81.37% | -341.69% | -172.96% | -562.17% |
| Operating CF Growth % | -165.73% | -41.2% | -24.57% | 25.61% | 388.85% | -89.99% | -37.73% | -412.27% | -63.17% | 1.73% | -57.36% | -1.62% | -24.86% | -67.37% | -41.71% | -40.3% | -93.82% | -54.62% | -43.16% | -43.64% |
| Net Income | -125.75M | -112.45M | -98.54M | -83.27M | 119.24M | -77.49M | -72.18M | -130.31M | -51.82M | -52.77M | -39.57M | -33.95M | -27.44M | -27.93M | -23.64M | -24.2M | 1.61M | -22.06M | -14.01M | -18.21M |
| Depreciation & Amortization | 614K | 1.12M | 1.14M | 1.2M | 1.03M | 1.23M | 1.13M | 643K | 1.01M | 1.1M | 1.08M | 1.02M | 1.03M | 998K | 960K | 922K | 925K | 860K | 808K | -523K |
| Stock-Based Compensation | 17.73M | 16.66M | 14.54M | 11.79M | 12.22M | 11.87M | 10.24M | 9.48M | 9.21M | 9.73M | 6.31M | 4.8M | 5.3M | 4.73M | 3.66M | 2.98M | 3M | 3.04M | 2.6M | 2.06M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -37.83M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -794K | -1.02M | -1.21M | -1.52M | -1.98M | -2.69M | -3.78M | -4.92M | -5.36M | -6.64M | -6.77M | 33.95M | -3.57M | -2.55M | -1.56M | -4.56M | -26.83M | -4.34M | -9.58M | -1.49M |
| Working Capital Changes | 14.72M | 7.48M | 8.9M | -18.69M | 11.71M | 4.61M | 4.24M | 3.44M | -2.28M | 15.7M | -4.87M | 8.26M | -5.5M | -8.71M | -7.26M | 1.49M | -2.88M | 2.5M | 537K | 1.5M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17K | -19K | 14K | 0 | 6.68M | -6.54M | 308K | -257K | 3.24M | -3.16M | 409K | 406K | -85K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.05M | 3.13M | -7.18M | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -7.5M | 8.89M | 3.05M | -858K | 1.19M | -364K | 2.73M | 2.98M | -3.94M | 9.7M | 0 | 1.75M | -699K | 1.6M | -12K | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | 78.65M | -155.93M | 118.95M | -97.53M | 41.77M | 45.92M | 79.82M | -197.11M | -20.04M | 68.56M | -353.97M | -111.94M | 51.35M | -121.38M | 23.52M | -10.28M | -18.68M | 13.32M | -17.76M | -413K |
| Capital Expenditures | -273K | -866K | -967K | -333K | -42K | -663K | -1.33M | -1.1M | -457K | -973K | -1.32M | -838K | -603K | -884K | -43K | 0 | -1.1M | -1.94M | -401K | -605K |
| CapEx % of Revenue | 2.67% | 9.78% | 14.74% | 3.06% | 0.02% | - | - | 15.74% | - | - | - | 21.36% | 7.5% | 24.94% | 0.55% | - | 3.71% | 33.17% | 3.53% | 20.42% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 111.11M | -51.95M | 120.5M | -23.56M | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -111.11M | 51.95M | -120.5M | 23.56M | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 3.69M | 359.21M | 1.18M | 2.13M | 301K | 1.21M | 26.14M | 2.75M | 286.5M | 39.18M | 349.11M | 140.89M | 27.83M | 191.06M | 2.93M | 324K | 95.7M | 491K | 653K | 688K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 3.69M | 142.77M | 1.18M | 2.13M | 301K | 1.21M | 25.01M | -405K | 286.5M | 36.32M | 349.11M | 127.42M | 25.98M | 153.81M | 2.56M | 324K | 95.55M | 491K | 653K | 688K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 216.44M | 0 | 0 | 0 | 0 | 1.13M | 3.16M | 0 | 2.86M | 0 | 13.48M | 1.85M | 37.26M | 366K | 0 | 147K | 0 | 0 | 0 |
| Net Change in Cash | -11.14M | 115.07M | 44.7M | -186.1M | 184.28M | -15.35M | 45.62M | -316.01M | 217.23M | 74.86M | -48.67M | 5.92M | 49.01M | 36.22M | -1.4M | -33.32M | 52.85M | -6.18M | -36.76M | -16.38M |
| Free Cash Flow | -93.75M | -89.08M | -76.14M | -90.83M | 142.17M | -63.14M | -61.67M | -122.76M | -49.69M | -33.85M | -45.14M | -24.59M | -30.78M | -34.34M | -27.89M | -23.37M | -25.27M | -21.93M | -20.05M | -17.26M |
| FCF Margin % | -915.39% | -1005.72% | -1160.63% | -835.13% | 68.41% | - | - | -1753.67% | - | - | - | -626.71% | -382.89% | -969.07% | -353.87% | -581.05% | -85.08% | -374.86% | -176.49% | -582.59% |
| FCF Growth % | -165.94% | -41.09% | -23.45% | 26.01% | 386.11% | -86.49% | -36.63% | -399.3% | -61.46% | 1.42% | -61.87% | -5.2% | -21.81% | -56.59% | -39.09% | -35.38% | -95.47% | -62.37% | -36.13% | -46.6% |
| FCF per Share | -0.91 | -0.97 | -0.86 | -1.03 | 1.59 | -0.71 | -0.70 | -1.50 | -0.58 | -0.43 | -0.60 | -0.38 | -0.51 | -0.61 | -0.58 | -0.49 | -0.61 | -0.57 | -0.52 | -0.45 |
| FCF Conversion (FCF/Net Income) | 0.74x | 0.78x | 0.76x | 1.09x | 1.19x | 0.81x | 0.84x | 0.93x | 0.95x | 0.62x | 1.11x | 0.70x | 1.10x | 1.20x | 1.18x | 0.97x | -14.96x | 0.91x | 1.40x | 0.91x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3K | 10K | 12K | 0 | 0 | 0 | 0 | 14K | 14K | 16K | 16K | 16K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |